Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Short-term Investments: 2010-2024

Historic Short-term Investments for Fresenius Medical Care AG (FMS) over the last 16 years, with Sep 2025 value amounting to $651.2 million.

  • Fresenius Medical Care AG's Short-term Investments rose 76.50% to $651.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $651.2 million, marking a year-over-year increase of 76.50%. This contributed to the annual value of $463.5 million for FY2024, which is 75.48% up from last year.
  • According to the latest figures from Q3 2025, Fresenius Medical Care AG's Short-term Investments is $651.2 million, which was up 21.11% from $537.6 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Short-term Investments registered a high of $651.2 million during Q3 2025, and its lowest value of $3.9 million during Q4 2021.
  • Its 3-year average for Short-term Investments is $416.9 million, with a median of $402.7 million in 2024.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Short-term Investments tumbled by 49.33% in 2021, and later surged by 6,369.98% in 2022.
  • Fresenius Medical Care AG's Short-term Investments (MRQ) stood at $3.9 million in 2021, then skyrocketed by 6,369.98% to $252.9 million in 2022, then increased by 3.88% to $262.7 million in 2023, then surged by 76.42% to $463.5 million in 2024, then soared by 40.49% to $651.2 million in 2025.
  • Its Short-term Investments stands at $651.2 million for Q3 2025, versus $537.6 million for Q2 2025 and $436.4 million for Q1 2025.